Blog
Pearl IRB’s uniqueness further distinguished with AAHRPP Accreditation
Pearl IRB joins an elite group of 23 commercial-independent IRBS’s and becomes just the second AAHRPP accredited organization in the state of Indiana by demonstrating high standards of excellence for quality, ethics, and protection in all levels of research. Pearl...
Gretchen Bowker to hold webinar via ComplianceOnline on March 19th
Pearl Pathways’ own COO and Co-Founder, Gretchen Bowker will be holding a webinar on FDA regulatory requirements for the manufacturing and commercialization of dietary supplements via ComplianceOnline. A few of the topics include a review of FDA regulations in the...
The Institute of Medicine shows support for clinical trial transparency
The US Institute of Medicine (IoM) has recently released a report supporting the movement for full transparency in clinical trial information saying, “releasing information is in the public interest and maximizes the contributions made by clinical trial participants...
US congressmen head initiative to improve clinical trial process
Fred Upton, chairman of the House Energy and Commerce Committee, and Rep. Diana DeGette have recently launched the 21st Century Cures initiative, a bill intended to improve clinical trials and expedite the drug and device approval process. Upton and Degette plan to...
Pearl Employee Publishes Article on RAPS.org
Pearl Pathways is proud of employee Heidi Strunk, as she earned a publication in the RAPS online journal Regulatory Focus. The article is located on RAPS.org (Login and Password required) and is entitled “Types of In Vitro Diagnostics: Clearing Up the Confusion.” By...